Navigation Links
Molecular Genetics Research to Fuel Growth in the qPCR and dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.
Date:10/31/2013

quisitions and other strategic industry activities of major companies. The report provides market estimates and projections for qPCR and dPCR Instrumentation in value (US$) for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, and Rest of Europe), Asia-Pacific (China, and Rest of Asia-Pacific), Middle East & Africa, and Latin America. The report also analyzes the global market for qPCR and dPCR Instrumentation by product segments including qPCR and dPCR. End-use segments analyzed include Educational/Research, Testing Laboratories, and Pharma.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Quantitative_Polymerase_Chain_Reaction_qPCR_and_digital_PCR_dPCR_Instrumentation_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. A nano car with molecular 4-wheel drive
2. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
3. Chemists become molecular sculptors, synthesizing tiny, molecular traps
4. Why Medicare Carrier Proposes Major Changes in the Handling of Code Stacked Molecular Test Claims is Topic of December 20 Audio Conference
5. Amsterdam Molecular Therapeutics Announces Negative Equity Position
6. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
7. The art of molecular carpet-weaving
8. Amsterdam Molecular Therapeutics Announces € 2.5 Million Equity Raise
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
11. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi ... patient recruitment services. The core expertise of PRC Clinical is focused on Clinical ...
(Date:7/29/2015)... ... July 29, 2015 , ... Costello served as Lead ... to protect the Orange County, Texas area from future storm surge flooding, such ... in determining several potential levee alignment alternatives for providing protection, Costello also balanced socio-economic ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... making good progress in evaluating the full range of capabilities of its unique ... tissue stem cells perform the day-to-day renewal and repair of normal tissues and ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4
... 20 Inverness Medical,Innovations, Inc. (Amex: IMA ), ... its financial results for the quarter,ended December 31, 2007., ... recorded net revenue of,$288.0 million compared to net revenue ... revenue increase was primarily due to increased,product sales in ...
... OSTE ), a leader in the emerging field of ... for the year,ending December 31, 2007 increased 5% to ... December 31, 2006. Revenue from "core" product,lines, DBM and ... increase of 15% over core product revenue of $58.8 ...
... Today at 10:00 CET, AMSTERDAM, February 20 Amsterdam Molecular,Therapeutics ... reported its full year 2007 results., Highlights ... - Cash & cash equivalents of EUR 51.3 million at ... lead product AMT 011 - Positive results of Phase I/II ...
Cached Biology Technology:Inverness Medical Innovations Announces Fourth Quarter 2007 Results 2Inverness Medical Innovations Announces Fourth Quarter 2007 Results 3Inverness Medical Innovations Announces Fourth Quarter 2007 Results 4Inverness Medical Innovations Announces Fourth Quarter 2007 Results 5Inverness Medical Innovations Announces Fourth Quarter 2007 Results 6Inverness Medical Innovations Announces Fourth Quarter 2007 Results 7Inverness Medical Innovations Announces Fourth Quarter 2007 Results 8Inverness Medical Innovations Announces Fourth Quarter 2007 Results 9Inverness Medical Innovations Announces Fourth Quarter 2007 Results 10Inverness Medical Innovations Announces Fourth Quarter 2007 Results 11Inverness Medical Innovations Announces Fourth Quarter 2007 Results 12Inverness Medical Innovations Announces Fourth Quarter 2007 Results 13Inverness Medical Innovations Announces Fourth Quarter 2007 Results 14Inverness Medical Innovations Announces Fourth Quarter 2007 Results 15Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 2Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 3Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 4Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 5Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7
(Date:7/23/2015)... , July 23, 2015 Research ... addition of the "Global Outlook of the ... offering. The global biometrics market ... public and commercial applications owing to the uptake ... witness a transformation that enhances the growth of ...
(Date:7/20/2015)... DENVER , July 20, 2015  Acuity ... Mobility Report: The Convergence of Commerce and Privacy" ... billion mobile biometric apps will be downloaded to ... users. The mobile biometrics market is projected to ... app revenue during the seven-year forecast period.    ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... HILO, HawaiiA team of scientists from the ... and two universities will begin research using sophisticated ... that have the most potential for ecological restoration. ... Susan Cordell, PSW research ecologist; Dr. Erin Questad, ...
... Jan. 24, 2012 Ingenuity Systems, a leading ... science researchers, today announced the general availability of ... fastest way to get biological meaning from expression ... for the statistical analysis and biological interpretation of ...
... recent Van Andel Research Institute (VARI) study published in the journal ... essential plant hormone could profoundly change our understanding of a key ... drugs for a variety of diseases. The study builds ... that was published in the journal Nature in 2009. ...
Cached Biology News:High-tech models help guide restoration efforts to save threatened plants 2Ingenuity Systems iReport Now Available: Fast, Accurate, Interactive Report for Gene Expression Data 2
General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
... Disposable, clear, APET plastic tray. Ideal ... identify those trays used for multipurposes. Pour ... liquid. A marker or label may be ... stacking trays on rockers or shakers for ...
ID clarifier: non-treated with lid...
... The Staccato Series of systems provide fast and reliable ... and drug development laboratories. Staccato systems are available in ... Custom Systems Series. ... All ...
Biology Products: